JP2023052777A5 - - Google Patents

Download PDF

Info

Publication number
JP2023052777A5
JP2023052777A5 JP2023012476A JP2023012476A JP2023052777A5 JP 2023052777 A5 JP2023052777 A5 JP 2023052777A5 JP 2023012476 A JP2023012476 A JP 2023012476A JP 2023012476 A JP2023012476 A JP 2023012476A JP 2023052777 A5 JP2023052777 A5 JP 2023052777A5
Authority
JP
Japan
Prior art keywords
cells
lymphocytes
polynucleotide
contacting
encoding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023012476A
Other languages
English (en)
Japanese (ja)
Other versions
JP7631387B2 (ja
JP2023052777A (ja
Filing date
Publication date
Priority claimed from JP2020150411A external-priority patent/JP7267976B2/ja
Application filed filed Critical
Publication of JP2023052777A publication Critical patent/JP2023052777A/ja
Publication of JP2023052777A5 publication Critical patent/JP2023052777A5/ja
Priority to JP2025017444A priority Critical patent/JP2025069383A/ja
Application granted granted Critical
Publication of JP7631387B2 publication Critical patent/JP7631387B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023012476A 2011-04-06 2023-01-31 末梢免疫機能を調節するための方法及び組成物 Active JP7631387B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025017444A JP2025069383A (ja) 2011-04-06 2025-02-05 末梢免疫機能を調節するための方法及び組成物

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161516637P 2011-04-06 2011-04-06
US61/516,637 2011-04-06
US201161541248P 2011-09-30 2011-09-30
US61/541,248 2011-09-30
JP2020150411A JP7267976B2 (ja) 2011-04-06 2020-09-08 末梢免疫機能を調節するための方法及び組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020150411A Division JP7267976B2 (ja) 2011-04-06 2020-09-08 末梢免疫機能を調節するための方法及び組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025017444A Division JP2025069383A (ja) 2011-04-06 2025-02-05 末梢免疫機能を調節するための方法及び組成物

Publications (3)

Publication Number Publication Date
JP2023052777A JP2023052777A (ja) 2023-04-12
JP2023052777A5 true JP2023052777A5 (https=) 2023-06-16
JP7631387B2 JP7631387B2 (ja) 2025-02-18

Family

ID=47139503

Family Applications (7)

Application Number Title Priority Date Filing Date
JP2014504019A Active JP5932970B2 (ja) 2011-04-06 2012-04-06 末梢免疫機能を調節するための方法及び組成物
JP2016089159A Active JP6134032B2 (ja) 2011-04-06 2016-04-27 末梢免疫機能を調節するための方法及び組成物
JP2017083713A Active JP6392926B2 (ja) 2011-04-06 2017-04-20 末梢免疫機能を調節するための方法及び組成物
JP2018153539A Active JP6981934B2 (ja) 2011-04-06 2018-08-17 末梢免疫機能を調節するための方法及び組成物
JP2020150411A Active JP7267976B2 (ja) 2011-04-06 2020-09-08 末梢免疫機能を調節するための方法及び組成物
JP2023012476A Active JP7631387B2 (ja) 2011-04-06 2023-01-31 末梢免疫機能を調節するための方法及び組成物
JP2025017444A Pending JP2025069383A (ja) 2011-04-06 2025-02-05 末梢免疫機能を調節するための方法及び組成物

Family Applications Before (5)

Application Number Title Priority Date Filing Date
JP2014504019A Active JP5932970B2 (ja) 2011-04-06 2012-04-06 末梢免疫機能を調節するための方法及び組成物
JP2016089159A Active JP6134032B2 (ja) 2011-04-06 2016-04-27 末梢免疫機能を調節するための方法及び組成物
JP2017083713A Active JP6392926B2 (ja) 2011-04-06 2017-04-20 末梢免疫機能を調節するための方法及び組成物
JP2018153539A Active JP6981934B2 (ja) 2011-04-06 2018-08-17 末梢免疫機能を調節するための方法及び組成物
JP2020150411A Active JP7267976B2 (ja) 2011-04-06 2020-09-08 末梢免疫機能を調節するための方法及び組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025017444A Pending JP2025069383A (ja) 2011-04-06 2025-02-05 末梢免疫機能を調節するための方法及び組成物

Country Status (6)

Country Link
US (6) US8785190B2 (https=)
EP (1) EP2694080B1 (https=)
JP (7) JP5932970B2 (https=)
CN (2) CN106692193B (https=)
CA (1) CA2832356C (https=)
WO (1) WO2012154344A1 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2694080B1 (en) * 2011-04-06 2018-03-14 SanBio, Inc. Methods and compositions for modulating peripheral immune function
CN112386681A (zh) 2012-01-27 2021-02-23 桑比欧公司 用于调节血管生成和血管发生的方法和组合物
CN104519891B (zh) 2012-05-16 2019-03-22 桑比欧公司 用于治疗创伤性脑损伤和用于调节神经原性细胞迁移的方法和组合物
WO2014058464A1 (en) 2012-10-09 2014-04-17 Sanbio, Inc. Methods and compositions for treatment of retinal degeneration
US20160008401A1 (en) * 2013-03-01 2016-01-14 Apceth Gmbh & Co. Kg Protection of the vascular endothelium from immunologically mediated cytotoxic reactions with human cd34-negative progenitor cells
EP2972368B1 (en) * 2013-03-15 2019-07-24 TiGenix, S.A.U. Lymphocyte biomarkers for determining the clinical response to cell therapy
US20160095885A1 (en) 2014-10-01 2016-04-07 WibiWorks Therapeutics, Inc. Induction Medium & Methods for Stem Cell Culture & Therapy
CN105985928A (zh) * 2015-02-10 2016-10-05 睿尔（天津）生物科技有限公司 一种增强间充质干细胞免疫调节能力的预处理培养方法
JP7237449B2 (ja) * 2015-02-27 2023-03-13 アイセル・ジーン・セラピューティクス・エルエルシー 血液系腫瘍を標的としたキメラ抗体受容体（ＣＡＲｓ）の構成およびその使用方法
CN106148276A (zh) * 2015-04-16 2016-11-23 中国科学院上海生命科学研究院 间充质干细胞在制备治疗神经退行性疾病的药物中的应用
CN107847657A (zh) * 2015-06-15 2018-03-27 生命治疗有限公司 用于诱导抗炎反应的组合物和方法
US11173179B2 (en) 2015-06-25 2021-11-16 Icell Gene Therapeutics Llc Chimeric antigen receptor (CAR) targeting multiple antigens, compositions and methods of use thereof
TWI833684B (zh) 2015-06-25 2024-03-01 美商生物細胞基因治療有限公司 嵌合抗原受體（ｃａｒ）、組合物及其使用方法
WO2017143219A2 (en) * 2016-02-18 2017-08-24 Viera Bioscience, Inc. Stimulation of therapeutic angiogenesis by t regulatory cells
EP3463482B1 (en) 2016-06-07 2021-10-06 The Brigham and Women's Hospital, Inc. Methods relating to t peripheral helper cells in autoantibody-associated conditions
JP7114490B2 (ja) 2016-06-24 2022-08-08 アイセル・ジーン・セラピューティクス・エルエルシー キメラ抗体受容体（ＣＡＲｓ）の構成およびその使用方法
WO2018125829A1 (en) 2016-12-28 2018-07-05 Sanbio, Inc. Cell delivery system and methods of operation thereof
CA3287539A1 (en) 2017-06-21 2026-03-02 Icell Gene Therapeutics Llc CHIMERIC ANTIGEN RECEPTORS (CARs), COMPOSITIONS AND METHODS THEREOF
EP4046642A4 (en) 2019-10-17 2022-12-21 TERUMO Kabushiki Kaisha CELL CULTURE FOR THE TREATMENT OF INFLAMMATORY DISEASES
CN111979186B (zh) * 2020-08-21 2022-04-08 遵义医科大学附属医院 一种快速高效体外扩增人间充质干细胞的方法及应用
CN116376828B (zh) * 2023-06-02 2023-08-11 成都云测医学生物技术有限公司 一种诱导CD4+T细胞生成Treg细胞的方法及应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5932970Y2 (ja) 1979-09-29 1984-09-14 トキナ−光学株式会社 ズ−ム式交換レンズにおける焦点距離の表示装置
JPS5993639U (ja) 1982-12-11 1984-06-25 愛知電機株式会社 撹拌装置における内容物の自動排出，投入装置
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
CZ295997B6 (cs) * 1996-11-07 2005-12-14 Lorantis Limited Farmaceutický prostředek s obsahem ligandu Notch a způsob tvorby T-buněk
US6280718B1 (en) 1999-11-08 2001-08-28 Wisconsin Alumni Reasearch Foundation Hematopoietic differentiation of human pluripotent embryonic stem cells
US6602711B1 (en) 2000-02-21 2003-08-05 Wisconsin Alumni Research Foundation Method of making embryoid bodies from primate embryonic stem cells
US7005252B1 (en) 2000-03-09 2006-02-28 Wisconsin Alumni Research Foundation Serum free cultivation of primate embryonic stem cells
US20030003090A1 (en) 2001-05-31 2003-01-02 Prockop Darwin J. Directed in vitro differentiation of marrow stromal cells into neural cell progenitors
WO2003011317A1 (en) * 2001-07-25 2003-02-13 Lorantis Limited Modulators of notch signalling for use in immunotherapy
US6887706B2 (en) 2001-10-03 2005-05-03 Wisconsin Alumni Research Foundation Method of in vitro differentiation of transplantable neural precursor cells from primate embryonic stem cells
DK1479767T3 (da) 2002-02-06 2013-11-25 Sanbio Inc Fremgangsmåde til differentiering/inducering af stromaceller fra knoglemarv til nerveceller ved overføring af Notch-gen
EP1737950B9 (en) 2004-04-12 2012-04-18 Sanbio, Inc. Cells exhibiting neuronal progenitor cell characteristics
PT1855700E (pt) 2005-03-07 2013-12-10 Sanbio Inc Utilização de materiais para tratamento de lesões do sistema nervoso central
WO2008102460A1 (en) 2007-02-23 2008-08-28 Sanbio Inc. Transplantation of bone marrow stromal cell-induced neural stem cells for promoting fuctional recovery after spinal cord injury
US8945919B2 (en) * 2007-08-15 2015-02-03 San Bio, Inc. Methods and composition for treating neural degeneration
EP2215216B1 (en) 2007-12-03 2018-05-30 SanBio, Inc. Extracellular matrix from pluripotent cells
ES2594229T3 (es) * 2008-04-30 2016-12-16 Sanbio, Inc. Células de regeneración nerviosa con alteraciones en la metilación del ADN
GB0814249D0 (en) * 2008-08-04 2008-09-10 Cellerix Sa Uses of mesenchymal stem cells
US8518397B2 (en) * 2009-08-14 2013-08-27 Case Western Reserve University Notch induced natural killer cell generation and therapeutic uses
EP2694080B1 (en) * 2011-04-06 2018-03-14 SanBio, Inc. Methods and compositions for modulating peripheral immune function
US20120263681A1 (en) * 2011-04-12 2012-10-18 Fujifilm Corporation Composition comprising cell and biocompatible polymer

Similar Documents

Publication Publication Date Title
JP2023052777A5 (https=)
Lamers-Kok et al. Natural killer cells in clinical development as non-engineered, engineered, and combination therapies
Gillis et al. Long-term culture of human antigen-specific cytotoxic T-cell lines.
Feng et al. Interferon-γ conditioning ex vivo generates CD25+ CD62L+ Foxp3+ regulatory T cells that prevent allograft rejection: potential avenues for cellular therapy
Berglund et al. Advances in umbilical cord blood cell therapy: the present and the future
Harashima et al. Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation
Bézie et al. Advances on CD8+ Treg cells and their potential in transplantation
Mahnke et al. Maintenance of long‐term tumour‐specific T‐cell memory by residual dormant tumour cells
Zandvliet et al. Combined CD8+ and CD4+ adenovirus hexon-specific T cells associated with viral clearance after stem cell transplantation as treatment for adenovirus infection
Greiner et al. Immunological and clinical impact of manipulated and unmanipulated DLI after allogeneic stem cell transplantation of AML patients
JP2014526244A5 (https=)
JP2019536461A5 (https=)
JP2018524987A5 (https=)
JP2005532803A5 (https=)
JP2021522839A5 (https=)
Lee et al. T lymphocyte development and activation in humanized mouse model
Reis et al. Recent developments in cellular immunotherapy for HSCT-associated complications
JP2020502262A5 (https=)
Welsh et al. How does B cell antigen presentation affect memory CD4 T cell differentiation and longevity?
JP2013537187A5 (https=)
JP2019530449A (ja) 幹細胞様メモリーｔ細胞の生成および養子免疫療法における使用
Lucarelli et al. Strategies to accelerate immune recovery after allogeneic hematopoietic stem cell transplantation
O’Reilly et al. Adoptive transfer of antigen-specific T-cells of donor type for immunotherapy of viral infections following allogeneic hematopoietic cell transplants
Velardi et al. Lymphokine production by T-cell clones after human bone marrow transplantation
McKenna et al. Umbilical cord blood: current status and future directions